{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:46:30Z","timestamp":1793040390573,"version":"4.5.0"},"reference-count":105,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["416910386 GRK 2573"],"award-info":[{"award-number":["416910386 GRK 2573"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022718","name":"Anneliese Pohl Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022718","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.critrevonc.2025.104823","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T03:10:14Z","timestamp":1751425814000},"page":"104823","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Elucidating the mechanistic role of ovarian cancer biomarkers: Lessons learnt from affinity-proteomics"],"prefix":"10.1016","volume":"214","author":[{"given":"Anna Mary","family":"Steitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Reinartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa M.","family":"Beutgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Pogge von Strandmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9669-091X","authenticated-orcid":false,"given":"Mar\u00eda","family":"G\u00f3mez-Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.critrevonc.2025.104823_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12113447","article-title":"Convergence of plasma metabolomics and proteomics analysis to discover signatures of high-grade serous ovarian cancer","volume":"12","author":"Ahn","year":"2020","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104823_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078716","article-title":"The FBI1\/Akirin2 target gene, BCAM, acts as a suppressive oncogene","volume":"8","author":"Akiyama","year":"2013","journal-title":"PLoS One"},{"issue":"17","key":"10.1016\/j.critrevonc.2025.104823_bib3","doi-asserted-by":"crossref","first-page":"15028","DOI":"10.1074\/jbc.M200497200","article-title":"Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4","volume":"277","author":"Asea","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104823_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095192","article-title":"Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability","volume":"9","author":"Assarsson","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104823_bib5","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ygyno.2010.12.355","article-title":"Increased circulating hepatocyte growth factor (HGF): a marker of epithelial ovarian cancer and an indicator of poor prognosis","volume":"121","author":"Aune","year":"2011","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104823_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11030290","article-title":"Cancer-associated fibroblasts' functional heterogeneity in pancreatic ductal adenocarcinoma","volume":"11","author":"Awaji","year":"2019","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104823_bib7","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s11373-006-9143-1","article-title":"Osteopontin in metastatic lesions as a prognostic marker in ovarian cancers","volume":"14","author":"Bao","year":"2007","journal-title":"J. Biomed. Sci."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104823_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11050698","article-title":"NECTIN4 (PVRL4) as putative therapeutic target for a specific subtype of high grade serous ovarian cancer-an integrative multi-omics approach","volume":"11","author":"Bekos","year":"2019","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104823_bib9","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/ijgo.13878","article-title":"Cancer of the ovary, fallopian tube, and peritoneum: 2021 update","volume":"155","author":"Berek","year":"2021","journal-title":"Int J. Gynaecol. Obstet."},{"key":"10.1016\/j.critrevonc.2025.104823_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2024.100830","article-title":"Secretome analysis using affinity proteomics and immunoassays: a focus on tumor biology","author":"Beutgen","year":"2024","journal-title":"Mol. Cell Proteom."},{"key":"10.1016\/j.critrevonc.2025.104823_bib11","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jprot.2016.08.023","article-title":"Complementarity of SOMAscan to LC-MS\/MS and RNA-seq for quantitative profiling of human embryonic and mesenchymal stem cells","volume":"150","author":"Billing","year":"2017","journal-title":"J. Proteom."},{"key":"10.1016\/j.critrevonc.2025.104823_bib12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12014-017-9169-6","article-title":"A multiplex platform for the identification of ovarian cancer biomarkers","volume":"14","author":"Boylan","year":"2017","journal-title":"Clin. Proteom."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104823_bib13","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1021\/pr201068b","article-title":"Systematic comparison of fractionation methods for in-depth analysis of plasma proteomes","volume":"11","author":"Cao","year":"2012","journal-title":"J. Proteome Res"},{"key":"10.1016\/j.critrevonc.2025.104823_bib14","doi-asserted-by":"crossref","DOI":"10.4061\/2009\/239204","article-title":"Proteomics: challenges, techniques and possibilities to overcome biological sample complexity","author":"Chandramouli","year":"2009","journal-title":"Hum. Genom. Proteom. 2009"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104823_bib15","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ygyno.2020.11.016","article-title":"Genetically predicted circulating protein biomarkers and ovarian cancer risk","volume":"160","author":"Considine","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.critrevonc.2025.104823_bib16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cca.2018.03.019","article-title":"Biomarker potential of IL-6 and VEGF-A in ascitic fluid of epithelial ovarian cancer patients","volume":"482","author":"Dalal","year":"2018","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104823_bib17","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/s41597-024-03536-1","article-title":"Machine learning-enhanced extraction of biomarkers for high-grade serous ovarian cancer from proteomics data","volume":"11","author":"De Silva","year":"2024","journal-title":"Sci. Data"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104823_bib18","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1309\/AJCPGXK0FR4MHIHB","article-title":"Nectin 4 overexpression in ovarian cancer tissues and serum: potential role as a serum biomarker","volume":"134","author":"Derycke","year":"2010","journal-title":"Am. J. Clin. Pathol."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104823_bib19","doi-asserted-by":"crossref","first-page":"273","DOI":"10.21873\/cgp.20380","article-title":"A multiplex biomarker assay improves the prediction of survival in epithelial ovarian cancer","volume":"20","author":"Dobilas","year":"2023","journal-title":"Cancer Genom. Proteom."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104823_bib20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10555-014-9547-8","article-title":"Proteomics of ovarian cancer: functional insights and clinical applications","volume":"34","author":"Elzek","year":"2015","journal-title":"Cancer Metastas.. Rev."},{"issue":"6404","key":"10.1016\/j.critrevonc.2025.104823_bib21","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1126\/science.aaq1327","article-title":"Co-regulatory networks of human serum proteins link genetics to disease","volume":"361","author":"Emilsson","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2025.104823_bib22","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12014-018-9216-y","article-title":"A two-step strategy for identification of plasma protein biomarkers for endometrial and ovarian cancer","volume":"15","author":"Enroth","year":"2018","journal-title":"Clin. Proteom."},{"key":"10.1016\/j.critrevonc.2025.104823_bib23","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s42003-019-0464-9","article-title":"High throughput proteomics identifies a high-accuracy 11 plasma protein biomarker signature for ovarian cancer","volume":"2","author":"Enroth","year":"2019","journal-title":"Commun. Biol."},{"key":"10.1016\/j.critrevonc.2025.104823_bib24","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s43856-022-00193-6","article-title":"Data-driven analysis of a validated risk score for ovarian cancer identifies clinically distinct patterns during follow-up and treatment","volume":"2","author":"Enroth","year":"2022","journal-title":"Commun. Med (Lond. )"},{"issue":"22","key":"10.1016\/j.critrevonc.2025.104823_bib25","doi-asserted-by":"crossref","first-page":"6601","DOI":"10.7150\/thno.37549","article-title":"Dual-platform affinity proteomics identifies links between the recurrence of ovarian carcinoma and proteins released into the tumor microenvironment","volume":"9","author":"Finkernagel","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.critrevonc.2025.104823_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.961448","article-title":"Pre-analytical processing of plasma and serum samples for combined proteome and metabolome analysis","volume":"9","author":"Gegner","year":"2022","journal-title":"Front Mol. Biosci."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104823_bib27","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/nm.3909","article-title":"The prognostic landscape of genes and infiltrating immune cells across human cancers","volume":"21","author":"Gentles","year":"2015","journal-title":"Nat. Med"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104823_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/proteomes10020016","article-title":"Applications of proteomics in ovarian cancer: dawn of a new era","volume":"10","author":"Ghose","year":"2022","journal-title":"Proteomes"},{"key":"10.1016\/j.critrevonc.2025.104823_bib29","doi-asserted-by":"crossref","DOI":"10.1177\/17588359241233225","article-title":"Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4","volume":"16","author":"Ghose","year":"2024","journal-title":"Ther. Adv. Med Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104823_bib30","doi-asserted-by":"crossref","first-page":"7802","DOI":"10.1038\/s41467-023-43282-3","article-title":"Proteomic characterization of epithelial ovarian cancer delineates molecular signatures and therapeutic targets in distinct histological subtypes","volume":"14","author":"Gong","year":"2023","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104823_bib31","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1038\/bjc.2014.55","article-title":"Elevated serum CXCL16 is an independent predictor of poor survival in ovarian cancer and may reflect pro-metastatic ADAM protease activity","volume":"110","author":"Gooden","year":"2014","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104823_bib32","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1021\/pr0703223","article-title":"A proteome resource of ovarian cancer ascites: integrated proteomic and bioinformatic analyses to identify putative biomarkers","volume":"7","author":"Gortzak-Uzan","year":"2008","journal-title":"J. Proteome Res"},{"key":"10.1016\/j.critrevonc.2025.104823_bib33","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.3389\/fonc.2019.01150","article-title":"Multi-platform affinity proteomics identify proteins linked to metastasis and immune suppression in ovarian cancer plasma","volume":"9","author":"Graumann","year":"2019","journal-title":"Front Oncol."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104823_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14071757","article-title":"Next generation plasma proteomics identifies high-precision biomarker candidates for ovarian cancer","volume":"14","author":"Gyllensten","year":"2022","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104823_bib35","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.ygyno.2018.03.050","article-title":"A novel multiple biomarker panel for the early detection of high-grade serous ovarian carcinoma","volume":"149","author":"Han","year":"2018","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104823_bib36","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","article-title":"Accessories to the crime: functions of cells recruited to the tumor microenvironment","volume":"21","author":"Hanahan","year":"2012","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104823_bib37","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1002\/eji.201344279","article-title":"IRF4 at the crossroads of effector T-cell fate decision","volume":"44","author":"Huber","year":"2014","journal-title":"Eur. J. Immunol."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104823_bib38","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1021\/acs.jproteome.2c00218","article-title":"Novel diagnostic biomarkers for high-grade serous ovarian cancer uncovered by data-independent acquisition mass spectrometry","volume":"21","author":"Huh","year":"2022","journal-title":"J. Proteome Res"},{"issue":"12","key":"10.1016\/j.critrevonc.2025.104823_bib39","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1021\/acs.jproteome.9b00503","article-title":"Mass spectrometry-based plasma proteomics: considerations from sample collection to achieving translational data","volume":"18","author":"Ignjatovic","year":"2019","journal-title":"J. Proteome Res"},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104823_bib40","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1158\/1078-0432.CCR-18-2946","article-title":"Ultrasensitive immunoprofiling of plasma extracellular vesicles identifies syndecan-1 as a potential tool for minimally invasive diagnosis of glioma","volume":"25","author":"Indira Chandran","year":"2019","journal-title":"Clin. Cancer Res"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104823_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-68249-2","article-title":"Large-scale proteomics reveals precise biomarkers for detection of ovarian cancer in symptomatic women","volume":"14","author":"Ivansson","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2025.104823_bib42","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.talanta.2017.03.091","article-title":"Depleting high-abundant and enriching low-abundant proteins in human serum: An evaluation of sample preparation methods using magnetic nanoparticle, chemical depletion and immunoaffinity techniques","volume":"170","author":"de Jesus","year":"2017","journal-title":"Talanta"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104823_bib43","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/1878-0261.12638","article-title":"Upregulation of BCAM and its sense lncRNA BAN are associated with gastric cancer metastasis and poor prognosis","volume":"14","author":"Jin","year":"2020","journal-title":"Mol. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104823_bib44","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1586\/14789450.5.4.551","article-title":"Advances in ovarian cancer proteomics: the quest for biomarkers and improved therapeutic interventions","volume":"5","author":"Jurisicova","year":"2008","journal-title":"Expert Rev. Proteom."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104823_bib45","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/cas.12987","article-title":"Ascites modulates cancer cell behavior, contributing to tumor heterogeneity in ovarian cancer","volume":"107","author":"Kim","year":"2016","journal-title":"Cancer Sci."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104823_bib46","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ygyno.2015.05.009","article-title":"Cytokine profiling of ascites at primary surgery identifies an interaction of tumor necrosis factor-alpha and interleukin-6 in predicting reduced progression-free survival in epithelial ovarian cancer","volume":"138","author":"Kolomeyevskaya","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104823_bib47","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1074\/mcp.M800313-MCP200","article-title":"Mining the ovarian cancer ascites proteome for potential ovarian cancer biomarkers","volume":"8","author":"Kuk","year":"2009","journal-title":"Mol. Cell Proteom."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104823_bib48","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1158\/0008-5472.CAN-11-2178","article-title":"A dynamic inflammatory cytokine network in the human ovarian cancer microenvironment","volume":"72","author":"Kulbe","year":"2012","journal-title":"Cancer Res"},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104823_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12082000","article-title":"Discovery of prognostic markers for early-stage high-grade serous ovarian cancer by maldi-imaging","volume":"12","author":"Kulbe","year":"2020","journal-title":"Cancers"},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104823_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0240418","article-title":"A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients","volume":"15","author":"Leandersson","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.critrevonc.2025.104823_bib51","article-title":"Determinants and functions of CAFs secretome during cancer progression and therapy","volume":"8","author":"Linares","year":"2020","journal-title":"Front Cell Dev. Biol."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104823_bib52","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1158\/0008-5472.CAN-10-1496","article-title":"IL-6 trans-signaling in formation and progression of malignant ascites in ovarian cancer","volume":"71","author":"Lo","year":"2011","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104823_bib53","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.ygyno.2011.05.039","article-title":"Comparison of candidate serologic markers for type I and type II ovarian cancer","volume":"122","author":"Lu","year":"2011","journal-title":"Gynecol. Oncol."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104823_bib54","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/eji.202048627","article-title":"Tc17 biology and function: novel concepts","volume":"50","author":"Luckel","year":"2020","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104823_bib55","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.canlet.2016.04.038","article-title":"Tumor microenvironment: the culprit for ovarian cancer metastasis?","volume":"377","author":"Luo","year":"2016","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104823_bib56","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.critrevonc.2015.07.006","article-title":"Proteomics in cancer research: are we ready for clinical practice?","volume":"96","author":"Maes","year":"2015","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104823_bib57","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12014-024-09477-6","article-title":"Neat plasma proteomics: getting the best out of the worst","volume":"21","author":"Metatla","year":"2024","journal-title":"Clin. Proteom."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104823_bib58","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41577-022-00746-9","article-title":"IL-17 and IL-17-producing cells in protection versus pathology","volume":"23","author":"Mills","year":"2023","journal-title":"Nat. Rev. Immunol."},{"issue":"2 Pt 1","key":"10.1016\/j.critrevonc.2025.104823_bib59","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/AOG.0b013e318224fce2","article-title":"Evaluation of the diagnostic accuracy of the risk of ovarian malignancy algorithm in women with a pelvic mass","volume":"118","author":"Moore","year":"2011","journal-title":"Obstet. Gynecol."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104823_bib60","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/s41416-021-01697-z","article-title":"Prospective evaluation of 92 serum protein biomarkers for early detection of ovarian cancer","volume":"126","author":"Mukama","year":"2022","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104823_bib61","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ygyno.2018.12.015","article-title":"A combined score of clinical factors and serum proteins can predict time to recurrence in high grade serous ovarian cancer","volume":"152","author":"Mysona","year":"2019","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104823_bib62","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1604","article-title":"Reciprocal crosstalk between Th17 and mesothelial cells promotes metastasis-associated adhesion of ovarian cancer cells","volume":"14","author":"Neuhaus","year":"2024","journal-title":"Clin. Transl. Med"},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104823_bib63","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/nm.2492","article-title":"Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth","volume":"17","author":"Nieman","year":"2011","journal-title":"Nat. Med"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104823_bib64","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2217\/fon.11.135","article-title":"Protein biomarkers of ovarian cancer: the forest and the trees","volume":"8","author":"Nolen","year":"2012","journal-title":"Future Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104823_bib65","first-page":"749","article-title":"Exosomes in the ascites of ovarian cancer patients: origin and effects on anti-tumor immunity","volume":"25","author":"Peng","year":"2011","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104823_bib66","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1021\/acs.jproteome.0c00641","article-title":"Multiplatform approach for plasma proteomics: complementarity of olink proximity extension assay technology to mass spectrometry-based protein profiling","volume":"20","author":"Petrera","year":"2021","journal-title":"J. Proteome Res"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104823_bib67","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/elps.200900286","article-title":"High-abundance protein depletion: comparison of methods for human plasma biomarker discovery","volume":"31","author":"Polaskova","year":"2010","journal-title":"Electrophoresis"},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104823_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2023.100578","article-title":"Mass spectrometry-based proteomics of epithelial ovarian cancers: a clinical perspective","volume":"22","author":"Qian","year":"2023","journal-title":"Mol. Cell Proteom."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104823_bib69","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1586\/14789450.3.4.409","article-title":"Effects of preanalytical variables on peptide and protein measurements in human serum and plasma: implications for clinical proteomics","volume":"3","author":"Rai","year":"2006","journal-title":"Expert Rev. Proteom."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104823_bib70","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13059-016-0956-6","article-title":"A transcriptome-based global map of signaling pathways in the ovarian cancer microenvironment associated with clinical outcome","volume":"17","author":"Reinartz","year":"2016","journal-title":"Genome Biol."},{"key":"10.1016\/j.critrevonc.2025.104823_bib71","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/1878-0261.12396","article-title":"Cell-type-selective pathways and clinical associations of lysophosphatidic acid biosynthesis and signaling in the ovarian cancer microenvironment","author":"Reinartz","year":"2019","journal-title":"Mol. Oncol. 23"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104823_bib72","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ijc.28335","article-title":"Mixed-polarization phenotype of ascites-associated macrophages in human ovarian carcinoma: correlation of CD163 expression, cytokine levels and early relapse","volume":"134","author":"Reinartz","year":"2014","journal-title":"Int J. Cancer"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104823_bib73","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.bbrc.2013.12.070","article-title":"In-depth proteomic analyses of ovarian cancer cell line exosomes reveals differential enrichment of functional categories compared to the NCI 60 proteome","volume":"445","author":"Sinha","year":"2014","journal-title":"Biochem Biophys. Res Commun."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104823_bib74","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12964-025-02128-9","article-title":"Basal cell adhesion molecule (BCAM) promotes mesothelial-to-mesenchymal transition and tumor angiogenesis through paracrine signaling","volume":"23","author":"Sivakumar","year":"2025","journal-title":"Cell Commun. Signal"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104823_bib75","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1176","article-title":"Basal cell adhesion molecule promotes metastasis-associated processes in ovarian cancer","volume":"13","author":"Sivakumar","year":"2023","journal-title":"Clin. Transl. Med"},{"key":"10.1016\/j.critrevonc.2025.104823_bib76","first-page":"61","article-title":"Tumor markers in screening for ovarian cancer","volume":"39","author":"Skates","year":"2001","journal-title":"Methods Mol. Med"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104823_bib77","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1158\/1940-6207.CAPR-18-0221","article-title":"Simultaneous measurement of 92 serum protein biomarkers for the development of a multiprotein classifier for ovarian cancer detection","volume":"12","author":"Skubitz","year":"2019","journal-title":"Cancer Prev Res (Phila)"},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104823_bib78","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.633","article-title":"The multicellular signalling network of ovarian cancer metastases","volume":"11","author":"Sommerfeld","year":"2021","journal-title":"Clin. Transl. Med"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104823_bib79","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1002\/mc.22583","article-title":"Stromal contributions to the carcinogenic process","volume":"56","author":"Spaw","year":"2017","journal-title":"Mol. Carcinog."},{"issue":"12","key":"10.1016\/j.critrevonc.2025.104823_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.108401","article-title":"TRAIL-dependent apoptosis of peritoneal mesothelial cells by NK cells promotes ovarian cancer invasion","volume":"26","author":"Steitz","year":"2023","journal-title":"iScience"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104823_bib81","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41419-020-2438-8","article-title":"Tumor-associated macrophages promote ovarian cancer cell migration by secreting transforming growth factor beta induced (TGFBI) and tenascin C","volume":"11","author":"Steitz","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.critrevonc.2025.104823_bib82","doi-asserted-by":"crossref","first-page":"14357","DOI":"10.1038\/ncomms14357","article-title":"Connecting genetic risk to disease end points through the human blood plasma proteome","volume":"8","author":"Suhre","year":"2017","journal-title":"Nat. Commun."},{"issue":"7708","key":"10.1016\/j.critrevonc.2025.104823_bib83","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41586-018-0175-2","article-title":"Genomic atlas of the human plasma proteome","volume":"558","author":"Sun","year":"2018","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104823_bib84","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S1470-2045(06)70939-1","article-title":"Mechanisms of transcoelomic metastasis in ovarian cancer","volume":"7","author":"Tan","year":"2006","journal-title":"Lancet Oncol."},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104823_bib85","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1074\/mcp.M300031-MCP200","article-title":"Characterization of the low molecular weight human serum proteome","volume":"2","author":"Tirumalai","year":"2003","journal-title":"Mol. Cell Proteom."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104823_bib86","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/ijc.34261","article-title":"A novel serum extracellular vesicle protein signature to monitor glioblastoma tumor progression","volume":"152","author":"Tzaridis","year":"2023","journal-title":"Int J. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104823_bib87","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics7010014","article-title":"A perspective on ovarian cancer biomarkers: past, present and yet-to-come","volume":"7","author":"Ueland","year":"2017","journal-title":"Diagnostics"},{"issue":"20","key":"10.1016\/j.critrevonc.2025.104823_bib88","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.1002\/1878-0261.13288","article-title":"Profiling of extracellular vesicles of metastatic urothelial cancer patients to discover protein signatures related to treatment outcome","volume":"16","author":"Viktorsson","year":"2022","journal-title":"Mol. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104823_bib89","article-title":"Proteomic analysis of ascitic extracellular vesicles describes tumour microenvironment and predicts patient survival in ovarian cancer","volume":"13","author":"Vyhlidalova Kotrbova","year":"2024","journal-title":"J. Extra Vesicles"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104823_bib90","doi-asserted-by":"crossref","DOI":"10.3390\/biom13010159","article-title":"The challenges and prospects of p53-based therapies in ovarian cancer","volume":"13","author":"Wallis","year":"2023","journal-title":"Biomolecules"},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104823_bib91","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.1021\/acs.jproteome.4c00104","article-title":"Deep plasma proteomics with data-independent acquisition: clinical study protocol optimization with a COVID-19 cohort","volume":"23","author":"Ward","year":"2024","journal-title":"J. Proteome Res"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104823_bib92","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1074\/mcp.M113.032136","article-title":"Proteomics analysis of cancer exosomes using a novel modified aptamer-based array (SOMAscan) platform","volume":"13","author":"Webber","year":"2014","journal-title":"Mol. Cell Proteom."},{"key":"10.1016\/j.critrevonc.2025.104823_bib93","article-title":"Proteomics analysis of vesicles isolated from plasma and urine of prostate cancer patients using a multiplex, aptamer-based protein array","volume":"5","author":"Welton","year":"2016","journal-title":"J. Extra Vesicles"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104823_bib94","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1023\/A:1008217129273","article-title":"Malignant effusions contain lysophosphatidic acid (LPA)-like activity","volume":"9","author":"Westermann","year":"1998","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2025.104823_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2021.100168","article-title":"Proximity extension assay in combination with next-generation sequencing for high-throughput proteome-wide analysis","volume":"20","author":"Wik","year":"2021","journal-title":"Mol. Cell. Proteom."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104823_bib96","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1074\/mcp.RA117.000400","article-title":"Proteotranscriptomics reveal signaling networks in the ovarian cancer microenvironment","volume":"17","author":"Worzfeld","year":"2018","journal-title":"Mol. Cell Proteom."},{"key":"10.1016\/j.critrevonc.2025.104823_bib97","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fonc.2017.00024","article-title":"The unique molecular and cellular microenvironment of ovarian cancer","volume":"7","author":"Worzfeld","year":"2017","journal-title":"Front Oncol."},{"key":"10.1016\/j.critrevonc.2025.104823_bib98","article-title":"Mag-Net: rapid enrichment of membrane-bound particles enables high coverage quantitative analysis of the plasma proteome","volume":"2023","author":"Wu","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.critrevonc.2025.104823_bib99","doi-asserted-by":"crossref","first-page":"758","DOI":"10.3389\/fcell.2020.00758","article-title":"Tumor microenvironment in ovarian cancer: function and therapeutic strategy","volume":"8","author":"Yang","year":"2020","journal-title":"Front Cell Dev. Biol."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104823_bib100","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.cell.2016.05.069","article-title":"Integrated proteogenomic characterization of human high-grade serous ovarian cancer","volume":"166","author":"Zhang","year":"2016","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104823_bib101","first-page":"1719","article-title":"Proteomics profiling of plasma exosomes in epithelial ovarian cancer: a potential role in the coagulation cascade, diagnosis and prognosis","volume":"54","author":"Zhang","year":"2019","journal-title":"Int J. Oncol."},{"key":"10.1016\/j.critrevonc.2025.104823_bib102","article-title":"Proteonano\u2122: a novel deep proteomics platform with 1000-plex profiling capacity and picogram sensitivity and its application in diabetic kidney disease","volume":"2023","author":"Zhao","year":"2023","journal-title":"bioRxiv"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104823_bib103","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1186\/s12885-018-4246-4","article-title":"GDF15 predict platinum response during first-line chemotherapy and can act as a complementary diagnostic serum biomarker with CA125 in epithelial ovarian cancer","volume":"18","author":"Zhao","year":"2018","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104823_bib104","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1038\/s41467-021-22767-z","article-title":"Next generation plasma proteome profiling to monitor health and disease","volume":"12","author":"Zhong","year":"2021","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104823_bib105","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/pmic.201200451","article-title":"The challenge of the proteome dynamic range and its implications for in-depth proteomics","volume":"13","author":"Zubarev","year":"2013","journal-title":"Proteomics"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842825002112?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842825002112?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T01:12:22Z","timestamp":1758589942000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842825002112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":105,"alternative-id":["S1040842825002112"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104823","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elucidating the mechanistic role of ovarian cancer biomarkers: Lessons learnt from affinity-proteomics","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104823","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104823"}}